As a wholly-owned subsidiary of Huawei Pharmaceutical Group Co., Ltd., Huawei (Beijing) Medical Management Co., Ltd., is responsible for medical consulting. It has established strategic partnership with national medical associations and institutions and has developed a group of national experts in hospital management, discipline construction and policy research to provide comprehensive consulting for medical institutions.
The Company provides policy consulting and technical services based on policies and regulations, industrial development planning, major projects, discipline construction, etc. issued by national ministries and commissions (Development and Reform Commission, Ministry of Finance, National Health Commission, Ministry of Science and Technology, National Administration of Traditional Chinese Medicine, etc.).
Centering on medical institutions’ management, consulting and service, the Company provides overall solutions for hospital development and planning, capacity enhancement, brand creation, etc. It focuses on improving the comprehensive capacity of hospital level evaluation, performance management, medical insurance management, traditional Chinese medical services and others and devotes to becoming a personal butler of hospital services.
1. Build a high-level network of public hospital
2. Construct key clinical special clusters
3. Build professional talent teams
4.Build a “three-in-one” smart hospital
5. Implement actions to improve medical quality
6. Implement actions to upgrade patient experience
7.Implement actions to optimize hospital management
8. Implement actions to enhance clinical research
1. Comprehensive quality management & evaluation and new concepts of continuous improvement
2. Interpretation of hospital-related professional standards and rules
3. Introduction to on-site tracking and inspecting methods
4. Introduction to statistics and evaluation of medical data
5. Judgment requirements for review result
6. Explanation of the use of Standards
7. Overview and interpretation of 183 standards of on-site inspection in Standards
8. The use of Rules
1. Explanation on collecting data of inpatient case on home page
2. Hospital satisfaction survey
3. External quality assessment of clinical labs
4. Relevant personnel information maintenance
5. Reformation on distribution system of hospital personnel
6. Post performance salary system
7. IT-based path for performance appraisal
1. The Pilot Program details
2. Specific considerations and arrangements for the 5 pilot cities
3. The relationship between deepening the price reform of medical services and the superb development of public hospitals
4. Ideas for the specific implementation of the Pilot Program
5. Impacts of price reform of medical services on medical institutions
6. Seven main contents of DIP business
7. Construction of medical insurance information system and data collection
8. Impacts of DIP business on import substitution of domestic products
ADD：2812/2815/2816/2817, Nanyin building, No. 2, East Third Ring North Road, Chaoyang District, Beijing
Tel：+86-10-61006202/61006203
Fax：+86-10-61006309
URL：sibtmf.cn
Copyright(C)2022,Huawei Pharmaceutical Group All Rights Reserved.
Supported by Toocle 31fabu Copyright Notice
